(118f) Biohybrid Polymersome-Mediated Enzyme Replacement Therapy for GM1 Gangliosidosis
AIChE Annual Meeting
2020
2020 Virtual AIChE Annual Meeting
Topical Conference: Chemical Engineers in Medicine
Chemical Engineering Principles Advancing Medicine
Monday, November 16, 2020 - 9:15am to 9:30am
Motivation: A lysosomal enzyme β-hexosaminidase A (HexA) is previously reported to be upregulated in GM1 gangliosidosis-affected felines, with HexA reaching normal levels after treatment with a viral vector4. To utilize this phenomenon, hyaluronic acid-b-poly(lactic acid) (HA-PLA) nanoparticles are used to encapsulate and deliver β-gal. HexA degrades hyaluronic acid5, and PLA undergoes acidic hydrolysis, thereby rendering the nanoparticles dual-responsive. Due to the presence of hydrophilic HA and hydrophobic PLA, the amphiphilic HA-PLA copolymer readily self-assembles into nanoparticles in the aqueous phase. The hydrophilic fraction (f) of a polymer is the ratio of the mass of hydrophilic block to the total mass. It dictates the structure of the self-assembled nanoparticles. The enzymatic nature of the cargo requires the use of vesicular nanoparticles called polymersomes. Functionalizing the surface of these nanoparticles with apolipoprotein E (ApoE), a ligand that binds to the low-density lipoprotein receptors expressed on the BBB, can facilitate the RMT across BBB6,7.
Methods: The HA-PLA polymer is synthesized through a two-step polymer conjugation process8. Briefly, hyaluronic acid (mol. wt. 5000 Da) is terminally functionalized with 1,4-diaminobutane to introduce an amine group at the reducing end. The aminated HA is then reacted with N-Hydroxysuccinimide (NHS) activated PLA in the presence of N,N-diisopropylethylamine. The reaction mixture is dialyzed against DI water to remove solvents and unreacted hyaluronic acid, followed by lyophilization to obtain the polymer HA-PLA. The polymer is subsequently used to synthesize nanoparticles using the solvent-injection method. The particle size and structure are analyzed using the dynamic light scattering (DLS) and transmission electron microscopy (TEM), respectively. The enzyme-based degradation of nanoparticles is determined using both DLS and TEM.
Results: The conjugated polymer is analyzed using Attenuated total reflectance-Fourier-transform infrared (ATR-FTIR) spectroscopy. The resultant spectrograph analysis demonstrated peaks corresponding to hyaluronic acid and poly(lactic acid) polymer blocks, confirming the conjugation. To prepare nanoparticles, HA-PLA is dissolved in dimethyl sulfoxide and injected into aqueous phase at controlled rate. DLS analysis of nanoparticles after filtration resulted in a peak diameter of 199.4 ± 42.6 nm. The TEM imaging of the nanoparticles revealed a vesicular structure. To determine the enzyme-based degradation of the polymersomes, they were incubated separately with hyaluronidase (HYAL) (cognate enzyme) and β-gal (non-cognate enzyme). HexA and HYAL have similar functionality with regards to the degradation of hyaluronic acid5. After incubating with the enzymes for 24 hours, particles incubated with HYAL presented a peak diameter (in particle size distribution of DLS analysis) at a smaller size indicating degradation. The peak diameter of the particles incubated with β-gal remained in the same range as before incubation indicating little to no degradation. For release study, polymersomes loaded with the dye Fluorescein Isothiocyanate-Dextran (FITC-D) as model encapsulant were incubated with HYAL and β-gal, and the fluorescence signal is monitored for hours. A higher release of FITC-D upon incubation with HYAL was observed compared to the release in β-gal incubation.
Conclusions: These results corroborate the conjugation of the hyaluronic acid and poly(lactic acid) blocks. The ability of the amphiphilic HA-PLA polymer to self-assemble into vesicular nanoparticles has been proven with the help of TEM. DLS analysis and TEM imaging show that the resultant nanoparticles can undergo enzymatic degradation in the presence of hyaluronidase. Release study showed the selective degradation of the nanoparticles in the presence of cognate enzyme (HYAL).
References:
1 Sandhoff, K. et al. J. Neurosci. 33, 10195â10208 (2013)
2 Kelly, J. M. et al. Progress in Neurobiology 152, 166â180 (2017)
3 Kelly, J. M. et al. Nanomedicine 12, 2591â2606 (2017)
4 McCurdy, V. J. et al. Sci. Transl. Med. 6, 231â279 (2014)
5 Gushulak, L. et al. J. Biol. Chem. 287, 16689â97 (2012)
6 Dehouck, B. et al. J. Cell Biol. 138, 877 LP â 889 (1997)
7 Wang, D. et al. Proc. Natl. Acad. Sci. U. S. A. 110, 2999â3004 (2013)
8 Deng, C. et al. J. Mater. Chem. B 6, 3163â3180 (2018)